Title |
WHO guidelines for treatment of tuberculosis: the missing links
|
---|---|
Published in |
International Journal of Clinical Pharmacy, June 2012
|
DOI | 10.1007/s11096-012-9657-8 |
Pubmed ID | |
Authors |
Muhammad Atif, Syed Azhar Syed Sulaiman, Asrul Akmal Shafie, Irfhan Ali, Mohamed Azmi Hassali, Fahad Saleem |
Abstract |
Worldwide, the treatment of tuberculosis is based on evidence-based guidelines developed by the World Health Organization (WHO) for national tuberculosis programs. However, the importance of health related quality of life, the adequate management of side effects associated with antituberculosis drugs and the elaboration of tuberculosis treatment outcome categories are a few issues that need to be addressed in forthcoming WHO guidelines for the treatment of tuberculosis. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Greece | 1 | 3% |
Unknown | 35 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 7 | 19% |
Student > Ph. D. Student | 5 | 14% |
Student > Postgraduate | 4 | 11% |
Student > Bachelor | 3 | 8% |
Researcher | 3 | 8% |
Other | 7 | 19% |
Unknown | 7 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 12 | 33% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 17% |
Agricultural and Biological Sciences | 4 | 11% |
Environmental Science | 1 | 3% |
Unspecified | 1 | 3% |
Other | 3 | 8% |
Unknown | 9 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 June 2012.
All research outputs
#15,245,883
of 22,668,244 outputs
Outputs from International Journal of Clinical Pharmacy
#761
of 1,071 outputs
Outputs of similar age
#94,088
of 147,842 outputs
Outputs of similar age from International Journal of Clinical Pharmacy
#10
of 22 outputs
Altmetric has tracked 22,668,244 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,071 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 147,842 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.